João B Calixto Selected Research

João B Calixto Research Topics

Disease

31	Inflammation (Inflammations) 01/2018 - 07/2000
29	Hyperalgesia 01/2021 - 10/2002
26	Pain (Aches) 01/2021 - 07/2000
16	Neuralgia (Stump Neuralgia) 06/2019 - 10/2002
13	Edema (Dropsy) 10/2017 - 11/2004
11	Colitis 01/2016 - 06/2007
9	Neoplasms (Cancer) 01/2020 - 02/2006
7	Chronic Pain 01/2021 - 10/2002
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 08/2016 - 02/2004
6	Necrosis 06/2019 - 05/2003
6	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 05/2007
5	Cognitive Dysfunction 01/2020 - 03/2010
5	Hypersensitivity (Allergy) 06/2019 - 04/2009
5	Neuroinflammatory Diseases 01/2017 - 10/2009
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2017 - 01/2011
4	Peripheral Nervous System Diseases (PNS Diseases) 01/2020 - 09/2011
4	Infections 01/2020 - 09/2009
4	Body Weight (Weight, Body) 11/2013 - 08/2011
4	Pleurisy (Pleuritis) 03/2007 - 02/2002
3	Glioma (Gliomas) 10/2015 - 06/2012
3	Cystitis 01/2014 - 12/2010
3	Asthma (Bronchial Asthma) 08/2008 - 02/2004
3	Visceral Pain 02/2006 - 04/2005
2	Brain Diseases (Brain Disorder) 01/2020 - 05/2010
2	Multiple Sclerosis 01/2017 - 02/2012
2	Weight Loss (Weight Reduction) 01/2017 - 01/2016
2	Memory Disorders (Memory Loss) 01/2017 - 02/2007

Drug/Important Bio-Agent (IBA)

22	KininsIBA 01/2020 - 07/2000
14	Freund's AdjuvantIBA 10/2017 - 10/2002
12	BradykininIBA 01/2021 - 12/2002
12	CarrageenanIBA 09/2012 - 02/2002
9	Pharmaceutical PreparationsIBA 12/2015 - 08/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2012 - 05/2003
8	Peptides (Polypeptides)IBA 01/2017 - 11/2006
8	Proteins (Proteins, Gene)FDA Link 10/2015 - 02/2006
7	icatibantIBA 06/2019 - 12/2002
7	TriterpenesIBA 07/2013 - 10/2002
7	Peroxidase (Myeloperoxidase)IBA 07/2013 - 02/2004
7	Capsaicin (Zostrix)FDA Link 04/2010 - 01/2003
6	ProstaglandinsIBA 11/2017 - 02/2004
6	SB 225002IBA 04/2014 - 10/2008
6	Dextran SulfateIBA 11/2013 - 01/2011
6	2,5-dichloro-4-bromophenol (B 2)IBA 12/2012 - 12/2002
5	CytokinesIBA 01/2018 - 02/2004
5	ChemokinesIBA 04/2014 - 04/2009
5	Gabapentin (Neurontin)FDA LinkGeneric 04/2014 - 10/2002
5	Interleukin-6 (Interleukin 6)IBA 10/2013 - 02/2002
5	Indomethacin (Indometacin)FDA LinkGeneric 01/2013 - 09/2006
5	Amyloid beta-PeptidesIBA 05/2010 - 02/2007
4	cinnamaldehyde (cinnamic aldehyde)FDA Link 01/2020 - 01/2016
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 09/2011
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2014 - 12/2010
4	Phosphotransferases (Kinase)IBA 11/2013 - 02/2004
4	sym-trinitrobenzeneIBA 10/2013 - 10/2008
4	Sulfonic AcidsIBA 10/2013 - 10/2008
4	eupholIBA 01/2013 - 01/2011
4	Celecoxib (Celebrex)FDA Link 01/2013 - 08/2004
4	Morphine (MS Contin)FDA LinkGeneric 11/2010 - 01/2003
4	Glutamic Acid (Glutamate)FDA Link 11/2006 - 01/2002
3	Type I Tumor Necrosis Factor ReceptorsIBA 06/2019 - 11/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2019 - 02/2004
3	Analgesics (Analgesic Drugs)IBA 01/2018 - 08/2004
3	caryophylleneIBA 10/2017 - 03/2007
3	2- (1,3- dimethyl- 2,6- dioxo- 1,2,3,6- tetrahydro- 7H- purin- 7- yl)- N- (4- isopropylphenyl)acetamideIBA 02/2017 - 03/2010
3	Protein Kinase CIBA 02/2017 - 08/2006
3	AnkyrinsIBA 02/2017 - 04/2013
3	Type C PhospholipasesIBA 02/2017 - 08/2006
3	LipidsIBA 08/2016 - 09/2006
3	Docosahexaenoic AcidsIBA 08/2016 - 08/2011
3	Dextrans (Dextran)FDA Link 01/2016 - 10/2012
3	SesquiterpenesIBA 12/2015 - 10/2009
3	polygodialIBA 12/2015 - 03/2004
3	Chemokine ReceptorsIBA 01/2014 - 02/2004
3	Messenger RNA (mRNA)IBA 10/2013 - 09/2009
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2013 - 03/2011
3	CannabinoidsIBA 07/2013 - 01/2011
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2013 - 08/2004
3	Interleukin-10 (Interleukin 10)IBA 12/2012 - 02/2002
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2012 - 10/2009
3	Pertussis ToxinIBA 01/2011 - 01/2003
3	2- ((3- (1,3- benzodioxol- 5- yl)- 3- (((6- methoxy- 2- naphthyl)sulfonyl)amino)propanoyl)amino)- 3- (4- ((2,6- dimethylpiperidinyl)methyl)phenyl)- N- isopropyl- N- methylpropanamideIBA 12/2010 - 09/2006
3	Thalidomide (Thalomid)FDA Link 11/2010 - 10/2005
3	LipopolysaccharidesIBA 04/2010 - 05/2003
3	Dinoprostone (PGE2)FDA Link 09/2007 - 08/2006
3	Opioid Analgesics (Opioids)IBA 11/2006 - 08/2004
3	Histamine (Histamine Dihydrochloride)FDA Link 09/2006 - 02/2003
2	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2021 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2020 - 01/2016
2	FR 173657IBA 01/2020 - 01/2003
2	Interleukin-17 (Interleukin 17)IBA 04/2019 - 01/2017
2	diacereinIBA 10/2017 - 12/2005
2	Matrix Metalloproteinases (MMPs)IBA 10/2017 - 02/2004
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 02/2017 - 02/2004
2	Interleukin-4 (Interleukin 4)IBA 01/2017 - 12/2012
2	Neuroprotective AgentsIBA 01/2017 - 11/2010
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2016 - 08/2011

Therapy/Procedure

8	Ligation 04/2014 - 10/2002
7	Therapeutics 01/2017 - 12/2006
6	Oral Administration 11/2013 - 10/2002
5	Drug Therapy (Chemotherapy) 01/2020 - 12/2010